单孔电视辅助胸腔镜解剖性肺切除术的中期生存结局:两中心经验
本研究回顾性分析两中心2014年1月至2017年2月接受单孔电视辅助胸腔镜解剖性肺切除术的307例患者,评估围手术期及中期生存结局。结果显示30天死亡率0.7%,90天并发症率20.1%,2年无病生存率和总生存率按AJCC第8版分期与分期数据一致,早期肺癌结果可接受,晚期患者需进一步评估。
要点
- 单孔胸腔镜解剖性肺切除的30天死亡率为0.7%,90天并发症率为20.1%。
- 按AJCC第8版,1A1期2年无病生存率92.3%、总生存率100%。
- 早期肺癌2年生存与AJCC第8版分期数据一致,晚期患者需进一步评估。
核心结论
- 单孔电视辅助胸腔镜解剖性肺切除术对早期肺癌可获得可接受的2年生存结局,与AJCC第8版分期2年生存数据一致;对晚期非小细胞肺癌患者需进一步评估。
研究设计与样本
- 回顾性研究,纳入2014年1月至2017年2月在科鲁尼亚大学医院微创胸外科(西班牙)和长庚纪念医院(台湾)接受单孔电视辅助胸腔镜解剖性肺切除术的患者,共307例。
主要发现
- 平均引流天数为3.90±2.98天,术后住院时间为5.03±3.34天。
- 总体30天死亡率为0.7%,90天并发症率为20.1%,90天死亡率为0.7%。
- 按AJCC第7版分类,1A、1B、2A、2B、3A期的2年无病生存率分别为80.6%、68.8%、51.0%、21.6%、47.6%,2年总生存率分别为93.4%、84.6%、66.7%、61.1%、58.5%。
- 按AJCC第8版分类,1A1、1A2、1A3、1B、2A、2B、3A期的2年无病生存率分别为92.3%、73.7%、75.2%、62.1%、55.6%、47.1%、42.1%,2年总生存率分别为100%、91.4%、93.4%、85.9%、72.7%、64.2%、60.3%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Single-port video-assisted thoracoscopic surgery (SPVATS) anatomical resection has been shown to be a feasible technique for lung cancer patients. Whether SPVATS has equivalent or better oncological outcomes for lung cancer patients remains controversial. The purpose of this study was to evaluate the perioperative and mid-term survival outcomes of SPVATS in 2 different medical centres. METHODS: We retrospectively reviewed patients who underwent SPVATS anatomical resections between January 2014 and February 2017 in Coruña University Hospital's Minimally Invasive Thoracic Surgery Unit (Spain) and Chang Gung Memorial Hospital (Taiwan). Survival outcomes were assessed by pathological stage according to the American Joint Committee on Cancer (AJCC) 7th and 8th classifications. RESULTS: In total, 307 patients were enrolled in this study. Mean drainage days and postoperative hospital stay were 3.90 ± 2.98 and 5.03 ± 3.34 days. The overall 30-day mortality, 90-day morbidity and mortality rate were 0.7%, 20.1% and 0.7%, respectively. The 2-year disease-free survival and 2-year overall survival of the cohort were 80.6% and 93.4% for 1A, 68.8% and 84.6% for 1B, 51.0% and 66.7% for 2A, 21.6% and 61.1% for 2B, 47.6% and 58.5% for 3A, respectively, following the AJCC 7th classification. By the AJCC 8th classification, these were 92.3% and 100% for 1A1, 73.7% and 91.4% for 1A2, 75.2% and 93.4% for 1A3, 62.1% and 85.9% for 1B, 55.6% and 72.7% for 2A, 47.1% and 64.2% for 2B and 42.1% and 60.3% for 3A. CONCLUSIONS: Our preliminary results revealed that SPVATS anatomical resection achieves acceptable 2-year survival outcomes for early-stage lung cancer and is consistent with AJCC 8th staging system 2-year survival data. For advanced stage non-small-cell lung cancer patients, further evaluation is warranted.
引用
- Wu CF, Fernandez R, de la Torre M, et al. Mid-term survival outcome of single-port video-assisted thoracoscopic anatomical lung resection: a two-centre experience. Eur J Cardiothorac Surg. 2018. PMID: 29514185. doi:10.1093/ejcts/ezy067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。